SAHMRI Research Showcase

Activity: Invited talks and oral presentations › Oral conference presentations and other invited talks

Description

Eadie LN, Schutz CE, Page EC, Lagonik E, Forgione MO, Rehn JA, Hughes TP, Yeung DT, White DL
Asciminib is a novel targeted inhibitor of the NUP214::ABL1 fusion gene in B-cell and T-cell acute lymphoblastic leukaemia
Oral Presentation
Adelaide, South Australia
Period15 Nov 2022 → 16 Nov 2022
Event titleSAHMRI Research Showcase
Event typeConference
LocationAustraliaShow on map
Degree of RecognitionLocal